These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

75 related articles for article (PubMed ID: 7969795)

  • 1. Analysis of glial fibrillary acidic protein in the cerebrospinal fluid of children investigated for encephalopathy.
    Ehlers S; Kyllerman M; Rosengren L
    Neuropediatrics; 1994 Jun; 25(3):129-33. PubMed ID: 7969795
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Glial fibrillary acidic protein and neurofilament in children with cerebral white matter abnormalities.
    Kristjánsdóttir R; Uvebrant P; Rosengren L
    Neuropediatrics; 2001 Dec; 32(6):307-12. PubMed ID: 11870586
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An ELISA for glial fibrillary acidic protein.
    Petzold A; Keir G; Green AJ; Giovannoni G; Thompson EJ
    J Immunol Methods; 2004 Apr; 287(1-2):169-77. PubMed ID: 15099765
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cerebrospinal fluid brain injury biomarkers in children: a multicenter study.
    Shahim P; Darin N; Andreasson U; Blennow K; Jennions E; Lundgren J; Månsson JE; Naess K; Törnhage CJ; Zetterberg H; Mattsson N
    Pediatr Neurol; 2013 Jul; 49(1):31-39.e2. PubMed ID: 23827424
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Consecutive analyses of cerebrospinal fluid axonal and glial markers in Parkinson's disease and atypical Parkinsonian disorders.
    Constantinescu R; Rosengren L; Johnels B; Zetterberg H; Holmberg B
    Parkinsonism Relat Disord; 2010 Feb; 16(2):142-5. PubMed ID: 19647470
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increased cerebrospinal fluid levels of neurofilament protein in progressive supranuclear palsy and multiple-system atrophy compared with Parkinson's disease.
    Holmberg B; Rosengren L; Karlsson JE; Johnels B
    Mov Disord; 1998 Jan; 13(1):70-7. PubMed ID: 9452329
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Glial fibrillary acidic protein in the cerebrospinal fluid: a possible indicator of prognosis in full-term asphyxiated newborn infants?
    Blennow M; Hagberg H; Rosengren L
    Pediatr Res; 1995 Mar; 37(3):260-4. PubMed ID: 7784132
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neuronal and glial cerebrospinal fluid protein biomarkers are elevated after West Nile virus infection.
    Petzold A; Groves M; Leis AA; Scaravilli F; Stokic DS
    Muscle Nerve; 2010 Jan; 41(1):42-9. PubMed ID: 19790244
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neurochemical aftermath of amateur boxing.
    Zetterberg H; Hietala MA; Jonsson M; Andreasen N; Styrud E; Karlsson I; Edman A; Popa C; Rasulzada A; Wahlund LO; Mehta PD; Rosengren L; Blennow K; Wallin A
    Arch Neurol; 2006 Sep; 63(9):1277-80. PubMed ID: 16966505
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neurochemical markers of brain damage in cerebrospinal fluid during induction treatment of acute lymphoblastic leukemia in children.
    Osterlundh G; Kjellmer I; Lannering B; Rosengren L; Nilsson UA; Márky I
    Pediatr Blood Cancer; 2008 Apr; 50(4):793-8. PubMed ID: 17973312
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neurological injury markers in children with septic shock.
    Hsu AA; Fenton K; Weinstein S; Carpenter J; Dalton H; Bell MJ
    Pediatr Crit Care Med; 2008 May; 9(3):245-51. PubMed ID: 18446104
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rapid immunoassay for the determination of glial fibrillary acidic protein (GFAP) in serum.
    Vissers JL; Mersch ME; Rosmalen CF; van Heumen MJ; van Geel WJ; Lamers KJ; Rosmalen FM; Swinkels LM; Thomsen J; Herrmann M
    Clin Chim Acta; 2006 Apr; 366(1-2):336-40. PubMed ID: 16405937
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Determination of lactic acid level in systemic liquids in children with progressive encephalopathies.
    Marszał E; Wojaczyńska-Stanek K; Pietruszewski J; Emich-Widera E; Bielińska-Bujniewicz E
    Med Sci Monit; 2002 Mar; 8(3):CR217-22. PubMed ID: 11889460
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Myoclonus and epilepsies in children].
    Fejerman N
    Rev Neurol (Paris); 1991; 147(12):782-97. PubMed ID: 1780607
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Elevated CSF glutamate in Rett syndrome.
    Hamberger A; Gillberg C; Palm A; Hagberg B
    Neuropediatrics; 1992 Aug; 23(4):212-3. PubMed ID: 1357572
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Glial fibrillary acidic protein: a marker of axonal Guillain-Barrè syndrome and outcome.
    Notturno F; Caporale CM; De Lauretis A; Uncini A
    Muscle Nerve; 2008 Jul; 38(1):899-903. PubMed ID: 18508349
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A sensitive ELISA for glial fibrillary acidic protein: application in CSF of children.
    Rosengren LE; Ahlsén G; Belfrage M; Gillberg C; Haglid KG; Hamberger A
    J Neurosci Methods; 1992 Sep; 44(2-3):113-9. PubMed ID: 1474847
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A sensitive ELISA for glial fibrillary acidic protein: application in CSF of adults.
    Rosengren LE; Wikkelsø C; Hagberg L
    J Neurosci Methods; 1994 Mar; 51(2):197-204. PubMed ID: 8051950
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased levels of GFAP in the cerebrospinal fluid in three subtypes of genetically confirmed Alexander disease.
    Kyllerman M; Rosengren L; Wiklund LM; Holmberg E
    Neuropediatrics; 2005 Oct; 36(5):319-23. PubMed ID: 16217707
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The cerebrospinal fluid level of glial fibrillary acidic protein is increased in cerebrospinal fluid from Alzheimer's disease patients and correlates with severity of dementia.
    Fukuyama R; Izumoto T; Fushiki S
    Eur Neurol; 2001; 46(1):35-8. PubMed ID: 11455181
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.